Pb2265: Risk Factors for Disease Progression of Mycosis Fungoides and Sézary Syndrome in East Asian Population

Abstract

The Cutaneous Lymphoma International Prognostic Index (CLIPi) was developed by Benton et al. in 2013 for the risk stratification of mycosis fungoides (MF) and Sezary syndrome (SS). While the CLIPi has been shown to be a useful prognostic tool for patients with MF/SS. It is unclear whether the CLIPi can be validated in an East Asianbased cohort and whether modifications are necessary to optimize its predictive value. Moreover, the primary outcome of the CLIPi was survival, and there is limited knowledge of the impact of some clinical and pathological risk factors on its performance.